Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
yet others at 90% {97,2147}. For pragmatic<br />
reasons, a 90% purity re q u i re m e n t<br />
o ffers a practical solution.<br />
Tumours exhibiting between 50 and 90%<br />
tubular growth pattern with other types<br />
should be regarded as mixed type of<br />
<strong>carcinoma</strong> (see Mixed type <strong>carcinoma</strong>s).<br />
Differential diagnosis<br />
Sclerosing adenosis (SA) can be distinguished<br />
from tubular <strong>carcinoma</strong> by its<br />
overall lobular arc h i t e c t u re and the<br />
marked compression and distortion of<br />
the glandular structures. Myoepithelial<br />
cells are always present in sclerosing<br />
adenosis and can be highlighted by<br />
immunostaining for actin. Similarly, a fully<br />
retained basement membrane can be<br />
shown by immunohistological staining for<br />
collagen IV and laminin in tubules of SA.<br />
Microglandular adenosis (MA) can be<br />
more difficult to differentiate because of<br />
the rather haphazard arrangement of the<br />
tubules, and lack of myoepithelial cells in<br />
the tubules. However, the tubules of MA<br />
are more rounded and regular and often<br />
contain colloid-like secretory material, at<br />
least focally, compared to the often angulated<br />
tubules of tubular carc i n o m a .<br />
Furthermore a ring of basement membrane<br />
is present around tubules of MA.<br />
Complex sclerosing lesions/radial scars<br />
have a typical arc h i t e c t u re with central<br />
f i b rosis and elastosis containing a few<br />
small, often distorted, tubular structures in<br />
which myoepithelial cells can be demonstrated.<br />
The surrounding glandular struct<br />
u res show varying degrees of dilatation<br />
and ductal epithelial hyperplasia.<br />
Immunophenotype<br />
Tubular <strong>carcinoma</strong> is nearly always<br />
e s t rogen and pro g e s t e rone re c e p t o r<br />
positive, has a low growth fraction, and<br />
is ERBB2 and EGFR negative {691,<br />
1 3 7 9 , 2 1 6 6 } .<br />
Genetics<br />
Tubular <strong>carcinoma</strong>s of the <strong>breast</strong> have a<br />
low frequency of genetic alterations<br />
when compared to other types of bre a s t<br />
c a rcinoma. Using LOH and CGH techniques,<br />
alterations have been found<br />
most frequently at chromosomes 16q<br />
(loss), 1q (gain), 8p (loss), 3p FHIT<br />
gene locus, and 11q ATM gene locus<br />
{1754,1779,2476, 3046}. Of part i c u l a r<br />
i n t e rest is the observation that other<br />
sites of chromosomal alteration pre v i-<br />
ously found at high levels in other types<br />
Fig. 1.25 <strong>Invasive</strong> cribriform <strong>carcinoma</strong>. The haphazard distribution of irregularly shaped and angulated invasive<br />
areas is in contrast with the rounded configuration of the ducts with cribriform DCIS on the left side of the field.<br />
of <strong>breast</strong> cancer are not seen, which<br />
implies that tubular <strong>carcinoma</strong> of the<br />
b reast is genetically distinct.<br />
Prognosis and predictive factors<br />
Pure tubular <strong>carcinoma</strong> has an excellent<br />
long term prognosis {409,410,552,771,<br />
1829,2081,2224} which in some series is<br />
similar to age matched women without<br />
<strong>breast</strong> cancer {691}. Recurrence following<br />
mastectomy or <strong>breast</strong> conservation<br />
treatment is rare and localized tubular<br />
<strong>carcinoma</strong>s are considered to be ideal<br />
candidates for <strong>breast</strong> conservation techniques.<br />
Following <strong>breast</strong> conservation,<br />
the risk of local recurrence is so low that<br />
some centres consider adjuvant radiotherapy<br />
unnecessary. Axillary node<br />
metastases occur infrequently, and when<br />
observed rarely involve more than one<br />
low axillary lymph node. There is little<br />
adverse effect of node positivity in tubular<br />
<strong>carcinoma</strong> {691,1471} and the use of<br />
systemic adjuvant therapy and axillary<br />
node dissection are considered unnecessary<br />
by some groups {691,2166}.<br />
<strong>Invasive</strong> cribriform <strong>carcinoma</strong><br />
Definition<br />
An invasive <strong>carcinoma</strong> with an excellent<br />
prognosis that grows in a cribriform pattern<br />
similar to that seen in intraductal<br />
cribriform <strong>carcinoma</strong>; a minor (90%) of an invasive cribriform patt<br />
e rn. The tumour is arranged as invasive<br />
islands, often angulated, in which<br />
well defined spaces are formed by<br />
a rches of cells (a sieve-like or cribrif<br />
o rm pattern). Apical snouts are a re g-<br />
ular feature. The tumour cells are small<br />
and show a low or moderate degree of<br />
nuclear pleomorphism. Mitoses are<br />
r a re. A prominent, reactive appearing,<br />
f i b roblastic stroma is present in many<br />
ICC. Intraductal <strong>carcinoma</strong>, generally<br />
of the cribriform type, is observed in as<br />
many as 80% of cases {2148}. Axillary<br />
lymph node metastases occur in 14.3%<br />
{2148}, the cribriform pattern being<br />
retained at these sites. Lesions showing<br />
a predominantly cribriform arrange-<br />
<strong>Invasive</strong> <strong>breast</strong> cancer<br />
27